In patients with Mammogram 4a, if it is a fibroadenoma, the patient can choose whether or not to have surgery; if it is a cancer, surgery will be performed if no metastasis has occurred.
In patients with molybdenum target 4a, the likelihood of malignancy is 2% to 9%, so some patients with 4a have a final puncture result of breast fibroadenoma. Fibroadenomas with a relatively large diameter will usually be recommended to the patient for surgical excision, while those with a smaller diameter can be selected for observation.
If the final puncture result is breast cancer, most patients will not be advised to undergo surgery if distant metastasis occurs, but will be treated with radiotherapy, chemotherapy, targeted therapy, and so on.
If distant metastasis has not occurred, small size and no axillary lymph node metastasis, surgery can be performed first, followed by non-surgical treatment; if the size is large (greater than 5 cm) and axillary lymph nodes are positive, neoadjuvant therapy can be performed before surgery, and adjuvant therapy can be performed after surgery.
Patients with molybdenum target 4a need timely breast surgery consultation and active management under doctor’s guidance.